<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01510340</url>
  </required_header>
  <id_info>
    <org_study_id>CE 11.184</org_study_id>
    <nct_id>NCT01510340</nct_id>
  </id_info>
  <brief_title>Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management</brief_title>
  <acronym>HIVMediconline</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Centre hospitalier de l'Université de Montréal (CHUM)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonds de la Recherche en Santé du Québec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre hospitalier de l'Université de Montréal (CHUM)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of an online virtual intervention in
      optimizing adherence to antiretroviral medication intake among Persons Living with HIV
      (PLHIV).
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    Changes &amp; upgrades in informatic infrastructure of the web-based intervention.
  </why_stopped>
  <start_date>January 2012</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence</measure>
    <time_frame>6 months</time_frame>
    <description>Adherence will be evaluated through a self-administered questionnaire that was developed for and validated on the targeted population (Godin, Gagné, &amp; Naccache, 2003). The questionnaire comprises seven items that serve to determine how many times a person forgets to take his or her medication. The questionnaire's validity was demonstrated (sensitivity: 71 %; specificity: 72%; correct classification: 72%; odds ratio: 6.15) using immunologic (CD4 count) and virologic (viral load) parameters as validation criteria. Adherence is defined as the intake of at least 95% of prescribed tablets.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">234</enrollment>
  <condition>HIV</condition>
  <arm_group>
    <arm_group_label>Web sites</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients assigned to this arm are given a list of Web sites where they can collect information related to their condition at their leisure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VIH-TAVIE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients assigned to this arm must follow the four interactive computer sessions</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>VIH-TAVIE</intervention_name>
    <description>The tailored virtual intervention is composed of four interactive computer sessions hosted by a virtual nurse who engages the PLHIV in a medication-intake self-management skills-learning process.</description>
    <arm_group_label>VIH-TAVIE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  have to be under ART for at least six months¸

          -  have internet access

        Exclusion Criteria:

          -  be pregnant

          -  active IV drug user

          -  actual diagnosis of psychiatric health problem
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>José Côté, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>CRCHUM, Université de Montréal</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gaston Godin, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yann-Gael Guéhéneuc, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Polytechnique</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cécile Tremblay, MD,Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>CRCHUM</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Joanne Otis, Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Universite du Quebec a Montreal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>José Côté</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H2X 0A9</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <link>
    <url>http://www.crsi.umontreal.ca</url>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 13, 2011</study_first_submitted>
  <study_first_submitted_qc>January 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 16, 2012</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adherence</keyword>
  <keyword>HIV</keyword>
  <keyword>antiretroviral therapy</keyword>
  <keyword>tailored web intervention</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

